172 related articles for article (PubMed ID: 24507927)
1. Synthesis of novel 5-(3-alkylquinolin-2-yl)-3-aryl isoxazole derivatives and their cytotoxic activity.
Sambasiva Rao P; Kurumurthy C; Veeraswamy B; Poornachandra Y; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2014 Mar; 24(5):1349-51. PubMed ID: 24507927
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 2-alkyl triazole-3-alkyl substituted quinoline derivatives and their cytotoxic activity.
Sambasiva Rao P; Kurumurthy C; Veeraswamy B; Santhosh Kumar G; Shanthan Rao P; Pamanji R; Venkateswara Rao J; Narsaiah B
Bioorg Med Chem Lett; 2013 Mar; 23(5):1225-7. PubMed ID: 23352638
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents.
Shakeel-u-Rehman ; Masood-ur-Rahman ; Tripathi VK; Singh J; Ara T; Koul S; Farooq S; Kaul A
Bioorg Med Chem Lett; 2014 Sep; 24(17):4243-6. PubMed ID: 25088398
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel 1,2,3-triazole/isoxazole functionalized 2H-Chromene derivatives and their cytotoxic activity.
Ratnakar Reddy K; Sambasiva Rao P; Jitender Dev G; Poornachandra Y; Ganesh Kumar C; Shanthan Rao P; Narsaiah B
Bioorg Med Chem Lett; 2014 Apr; 24(7):1661-3. PubMed ID: 24641975
[TBL] [Abstract][Full Text] [Related]
5. Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors.
Makawana JA; Sangani CB; Lin L; Zhu HL
Bioorg Med Chem Lett; 2014 Apr; 24(7):1734-6. PubMed ID: 24630412
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new chromeno-annulated cis-fused pyrano[4,3-c]isoxazole derivatives via intramolecular nitrone cycloaddition and their cytotoxicity evaluation.
Bejjanki NK; Venkatesham A; Madda J; Kommu N; Pombala S; Kumar CG; Prasad KR; Nanubolu JB
Bioorg Med Chem Lett; 2013 Jul; 23(14):4061-6. PubMed ID: 23764302
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.
Liu T; Dong X; Xue N; Wu R; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Sep; 17(17):6279-85. PubMed ID: 19665898
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 1,2,3-triazole substituted-N-alkyl/aryl nitrone derivatives, their anti-inflammatory and anticancer activity.
Sambasiva Rao P; Kurumurthy C; Veeraswamy B; Santhosh Kumar G; Poornachandra Y; Ganesh Kumar C; Vasamsetti SB; Kotamraju S; Narsaiah B
Eur J Med Chem; 2014 Jun; 80():184-91. PubMed ID: 24780595
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents.
Kumbhare RM; Kosurkar UB; Janaki Ramaiah M; Dadmal TL; Pushpavalli SN; Pal-Bhadra M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5424-7. PubMed ID: 22858144
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
[TBL] [Abstract][Full Text] [Related]
13. Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells.
Adsule S; Barve V; Chen D; Ahmed F; Dou QP; Padhye S; Sarkar FH
J Med Chem; 2006 Nov; 49(24):7242-6. PubMed ID: 17125278
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers.
Lo WF; Chou YW; Tseng CH; Shiu YH; Chen YW; Yang SC; Chen YL; Lin MF; Tzeng CC
Anticancer Agents Med Chem; 2015; 15(4):493-500. PubMed ID: 25612680
[TBL] [Abstract][Full Text] [Related]
15. Discovery and optimization of novel 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazones as c-Met kinase inhibitors.
Qi B; Mi B; Zhai X; Xu Z; Zhang X; Tian Z; Gong P
Bioorg Med Chem; 2013 Sep; 21(17):5246-60. PubMed ID: 23838381
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity evaluation of some novel 1-(3-(aryl-4,5-dihydroisoxazol-5-yl)methyl)-4-trihalomethyl-1H-pyrimidin-2-ones in human cancer cells.
Lobo MM; Viau CM; Dos Santos JM; Bonacorso HG; Martins MA; Amaral SS; Saffi J; Zanatta N
Eur J Med Chem; 2015 Aug; 101():836-42. PubMed ID: 26275603
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activities of amino acid-conjugate derivatives of abietane-type diterpenoids against human cancer cell lines.
Ukiya M; Kawaguchi T; Ishii K; Ogihara E; Tachi Y; Kurita M; Ezaki Y; Fukatsu M; Kushi Y; Akihisa T
Chem Biodivers; 2013 Jul; 10(7):1260-8. PubMed ID: 23847070
[TBL] [Abstract][Full Text] [Related]
18. Efficient regioselective synthesis and potential antitumor evaluation of isoxazolo[5,4-b]pyridines and related annulated compounds.
Hamama WS; Ibrahim ME; Zoorob HH
Arch Pharm (Weinheim); 2012 Jun; 345(6):468-75. PubMed ID: 22383332
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety.
Li S; Huang Q; Liu Y; Zhang X; Liu S; He C; Gong P
Eur J Med Chem; 2013 Jun; 64():62-73. PubMed ID: 23644189
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor cytotoxicity evaluation of pyrido[4,3,2-de]quinolines and isoquinolino[6,5,4,3-cde]quinolines.
Ding Q; Jia G; Lown JW
Anticancer Drug Des; 2000 Apr; 15(2):99-108. PubMed ID: 10901297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
